Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Herbicide |
DME Modulation |
Atrazine up-regulates the expression of DME MT1A |
[1] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Cadmium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Cadmium induces the drug-metabolizing activity of DME MT1A |
[2] |
Chloropicrin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01247
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Chloropicrin up-regulates the expression of DME MT1A |
[3] |
Ochratoxin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01407
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Ochratoxin A up-regulates the expression of DME MT1A |
[4] |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Azaspiracid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01502
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Marine Algal Toxin |
DME Modulation |
Azaspiracid up-regulates the expression of DME MT1A |
[5] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene inhibits the expression of DME MT1A |
[6] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME MT1A |
[7], [8] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Dust |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Dust up-regulates the expression of DME MT1A |
[9] |
Particulate matter |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00919
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Particulate matter up-regulates the expression of DME MT1A |
[10] |
Tobacco smoke pollution |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00821
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Mixture |
DME Modulation |
Tobacco smoke pollution inhibits the drug-metabolizing activity of DME MT1A |
[11] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Grape seed proanthocyanidins |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00758
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Plant Extract |
DME Modulation |
Grape seed proanthocyanidins inhibits the expression of DME MT1A |
[12] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 14 Xenobiotics
|
Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide inhibits the expression of DME MT1A |
[13] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME MT1A |
[14] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME MT1A |
[15] |
Cupric chloride |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00407
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cupric chloride up-regulates the expression of DME MT1A |
[16] |
Cytarabine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00097
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cytarabine inhibits the expression of DME MT1A |
[17] |
Dexamethasone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dexamethasone up-regulates the expression of DME MT1A |
[18] |
Dronabinol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00115
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dronabinol up-regulates the expression of DME MT1A |
[19] |
Estradiol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol inhibits the expression of DME MT1A |
[20] |
Nitroprusside |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00398
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Nitroprusside up-regulates the expression of DME MT1A |
[21] |
Progesterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00094
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Progesterone up-regulates the expression of DME MT1A |
[22] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME MT1A |
[23] |
Benzoic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00447
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Benzoic acid up-regulates the expression of DME MT1A |
[24] |
Silver nitrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00511
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Silver nitrate up-regulates the expression of DME MT1A |
[25] |
Zinc sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00460
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Zinc sulfate up-regulates the expression of DME MT1A |
[26] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Diphenylcyclopropenone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00612
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diphenylcyclopropenone up-regulates the expression of DME MT1A |
[24] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
AM-80 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00622
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
AM-80 up-regulates the expression of DME MT1A and leads to increasing the drug-metabolizing activity of this enzyme |
[27] |
Salicylic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00546
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
Salicylic acid up-regulates the expression of DME MT1A |
[28] |
Arecoline |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00578
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Arecoline up-regulates the expression of DME MT1A |
[29] |
Genistin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00645
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Genistin up-regulates the expression of DME MT1A |
[30] |
Hydroxytamoxifen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00634
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Hydroxytamoxifen up-regulates the expression of DME MT1A |
[31] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite induces the drug-metabolizing activity of DME MT1A |
[32], [33] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
(+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug in Preclinical Study |
DME Modulation |
(+)-JQ1 inhibits the expression of DME MT1A |
[34], [35] |
K-7174 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
K-7174 inhibits the expression of DME MT1A |
[36] |
Other Chemical Compound(s) or Element(s) |
Cosmetic Additive |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Hydroxycitronellal |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cosmetic Additive |
DME Modulation |
Hydroxycitronellal up-regulates the expression of DME MT1A |
[24] |
Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cupric oxide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00840
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Chemical Compound |
DME Modulation |
Cupric oxide up-regulates the expression of DME MT1A |
[37], [15] |
|
|
|
|
|
|